Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CS-4771 Phase 1 randomized double-blind placebo-controlled ascending dose study in healthy Japanese subjects
jRCT2080221894Phase 1
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial comparing CS-4771 with Placebo (2 arms). Primary endpoints: Safety and tolerability of CS-4771, Pharmacokinetics of CS-4771 and 1 more.
02
Drugs
mirogabalin
Beyond the preview
Go deeper on jRCT2080221894.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221894.